India caps FDI in pharma at 49%

India |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jul, 2012

Bangalore: An inter-ministerial group (IMG) on foreign direct investment (FDI) in pharmaceuticals, headed by Mr Shanktikanta Das, additional secretary, Department of Economic Affairs (DEA),...Read more

BMS Foundation awards $1.6 mn to fight diabetes in India

India |  News | By BioSpectrum Bureau  | 0 Comment | 07 Aug, 2012

Singapore: Bristol-Myers Squibb (BMS) Foundation will provide $1.6 million in grants to four healthcare institutions in India to help improve diabetes education, prevention and care, increa...Read more

Serum Institute acquires Dutch biologics company

India |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jul, 2012

Mumbai: Serum Institute of India, the flagship company of the over $1 bn Poonawalla Group and India's largest vaccine company, has acquired Bilthoven Biologicals of Netherlands. Through the...Read more

India to examine drug approval procedures

India |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

Bangalore: India has set up a committee to examine the validity of scientific and statutory basis adopted for approval of new drugs without clinical trials. The government announced the dec...Read more

Egypt seeking Indian pharma investment

India |  News | By BioSpectrum Bureau  | 0 Comment | 05 Dec, 2013

Singapore: With analysts predicting great growth from overseas for the Indian pharmaceutical industry, Egypt recently joined in the list of countries keen on receiving investment from the s...Read more

GE Healthcare unveils first PET/CT designed in India

India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

Singapore: The new Discovery IQ is the result of $15 Million (INR 90 Crores) investment, and 3 years of close collaborative development with Indian nuclear medicine physicians and oncologis...Read more

India lags behind neighbors on key health measures

India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Bangalore: Indians are living longer lives, but illness and disability of a very high order and relatively early death remain severe health care challenges. What should cause concern to he...Read more

Gerresheimer net income rises by 22%

India |  News | By BioSpectrum Bureau  | 0 Comment | 15 Feb, 2013

Singapore: Gerresheimer, one-of-the-leading worldwide partners of the pharma and healthcare industry, has closed the 2012 financial year with significant growth in revenues and profits. Ger...Read more

FDA gets biomarker database license from GVK Bio

India |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 05 Feb, 2013

Singapore: GVK Biosciences is extending its Clinical Biomarker Database (Gobiom) license to the Biomarker Qualification Group of the US FDA. The Gobiom database, which has the latest and re...Read more

'Start-up services should meet customers' needs'

India |  Influencers | By BioSpectrum Bureau  | 0 Comment | 21 Apr, 2014

Mr Sam Santhosh, the founder of MedGenome has been an entrepreneur, with over 20 years' of experience in the software industry. Currently, he is also the CEO and chairman of SciGenom Labs. ...Read more

BASF to launch production line for catalysts required for APIs

India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Bangalore: BASF will launch a production line for precious metal-based fine chemical catalysts at the company's manufacturing site in Mangalore, India. These catalysts are important for th...Read more

Minister: HIV in India down by 56%

India |  News | By BioSpectrum Bureau  | 0 Comment | 15 Aug, 2012

New Delhi: During the last decade in India, HIV infections have declined by 56 percent from 2.7 lakh in 2000 to 1.2 lakh in 2009. This was stated by Mr Ghulam Nabi Azad, minister, Health an...Read more

India's clinical trial industry should look into the mirror

India |  Opinion | By BioSpectrum Bureau  | 0 Comment | 12 Jul, 2013

What are the major issues confronting India's bioscience sector now? On top of every one's mind is the uncertainty over parliamentary approval to the new biotech regulatory legislation and ...Read more

NATCO wins compulsory license for anti-cancer drug

India |  News | By BioSpectrum Bureau  | 0 Comment | 16 Mar, 2012

In a landmark decision, Hyderabad-based NATCO Pharma has been granted compulsory license for Sorafenib Tosylate sold under the brand name of Nexavar owned by Bayer. Nexavar is the first-li...Read more

Infosys joins movement against child diarrheal deaths

India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Aug, 2012

Bangalore: Information technology services major Infosys has made a commitment to work with the MDG Health Alliance, the United Nations Foundation, and the Clinton Health Access Initiative...Read more

Philips opens manufacturing facility in India

India |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jun, 2012

Bangalore: In line with its strategy to expand the company's industrial footprint in India, Royal Philips Electronics commenced operations at its first greenfield manufacturing facility for...Read more

IPDA wants export ban on medicines lifted

India |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 06 Jul, 2014

Singapore: The Maharashtra Food and Drug Administration (FDA) in India has enforced a ban on export of pharma products through parcel posts in February this year. Pharma companies in Mahara...Read more

Cadila chairman Indravadan Modi passes away

India |  News | By BioSpectrum Bureau  | 0 Comment | 27 Nov, 2012

Bangalore: Veteran industrialist and one of pioneers of Indian pharmaceuticals industry Mr Indravadan Modi, the chairman of Cadila Pharmaceuticals and group companies, passed away on Novemb...Read more